|
|
{{if listFind(vars.channel_names, "MSIF News")}} {{endif}}  {{if listFind(vars.channel_names, "MSIF News")}} {{endif}} {{if listFind(vars.channel_names, "MSIF News")}} 
MSIF News
{{endif}}
|
{{if listFind(vars.channel_names, "People With MS News")}} {{endif}}  {{if listFind(vars.channel_names, "People With MS News")}} {{endif}} {{if listFind(vars.channel_names, "People With MS News")}} 
People with MS News
{{endif}}
|
{{if listFind(vars.channel_names, "Research News")}} {{endif}}  {{if listFind(vars.channel_names, "Research News")}} {{endif}} {{if listFind(vars.channel_names, "Research News")}} 
Research News
{{endif}}
|
{{if listFind(vars.channel_names, "MS Society News")}} {{endif}}  {{if listFind(vars.channel_names, "MS Society News")}} {{endif}} {{if listFind(vars.channel_names, "MS Society News")}} 
MS News
{{endif}}
|
|
|
|
Making Connections
The Great New Zealand trek
The Trek is New Zealand’s most ambitious outdoor event taking an army of trekkers the length of the country. Participants can choose to mountain bike ride, ride a horse, or walk the distance, finishing each evening at the traveling campsite complete with gourmet mess hall, bar and hot showers.
The Great New Zealand trek is held over 12 stages (one each year) and traverses from the far North to the deep South of New Zealand in a ‘Race Towards a Cure’ for Multiple Sclerosis.
For more infomation visit www.greatnewzealandtrek.com.
|
{{if listFind(vars.channel_names, "MSIF News")}}
|
|
MSIF News
 |
 |
| Summaries of new MSIF activities, events, projects, programmes, resources, publications and more. |
Are we making an impact?
MSIF is currently asking the question, are we making an impact? Are our projects improving the quality of life of people with MS and stimulating international MS research?
We believe we are making a difference, but what do you think? Please tell us by taking part in our 5 minute survey. Your feedback - whether you are a person affected by MS, someone who works or volunteers at an MS society, or you work as an MS health professional or scientist - will help make sure we are doing the best we can for people with MS around the globe.
read more
|
|
|
|
{{endif}}
{{if listFind(vars.channel_names, "People With MS News")}}
|
|
People with MS News
 |
 |
| Summaries of news, views and achievements from people with MS around the world. |
|
|
|
|
{{endif}}
{{if listFind(vars.channel_names, "Research News")}}
|
|
Research News
 |
 |
| Summaries of all the latest research findings on MS selected by a team based at the Institute of Neurology, London. |
White matter plasticity and enhanced remyelination in the maternal CNS
This study investigates whether MS remission during pregnancy could be due to enhanced remyelination, with positive results. The hormone prolactin is identified as a potential therapeutic agent.
authors: Gregg C, Shikar V, Larsen P, Mak G, Chojnacki A, Yong VW, Weiss S.
source: J Neurosci. 2007 Feb 21;27(8):1812-23
read more
Helminths as governors of immune-mediated inflammation
This paper summarises recent studies which have found that parasitic worms may stimulate our immune sytems and protect us against inflammatory conditions.
authors: Elliott DE, Summers RW, Weinstock JV
source: Int J Parasitol. 2006 Dec 28; [Epub ahead of print]
read more
A secondary progressive clinical course is uncommon in neuromyelitis optica
This study in 96 patients with neuromyelitis optica (NMO), a condition involving inflammation in the spinal cord and optic nerves, shows that a secondary progressive course is very rare. The authors suggest that this demonstrates a dissociation between relapses and progression in demyelinating conditions.
authors: Wingerchuk DM, Pittock SJ, Lucchinetti CF, Lennon VA, Weinshenker BG
source: Neurology. 2007 Feb 20;68(8):603-5
read more
APOE epsilon4 is associated with impaired verbal learning in patients with MS
This Greek study in 125 MS patients investigated the association of the 4 allelle of the gene APOE, which has been linked to Alzheimer’s disease, with cognitive function. Having the gene was associated with an increased risk of cognitive impairment.
authors: Koutsis G, Panas M, Giogkaraki E, Potagas C, Karadima G, Sfagos C, Vassilopoulos D.
source: Neurology. 2007 Feb 20;68(8):546-9
read more
|
|
|
|
{{endif}}
{{if listFind(vars.channel_names, "MS Society News")}}
{{endif}}
|
|
Tell a friend

The email you subscribed with us is {{print email}}
Within this newsletter the following options are available: MSIF News; People with MS News; Research News and MS Society News. To amend your options please login to the 'My world of MS' online community where you can also read diary entries from people affected by MS, leave your own diary entries and send messages to other users. You can also change your email address, contact details and subscribe to our free publications.
If you have an RSS News Reader you can get the latest news syndicated to you by copying the following link to your Reader: Syndicate.
If you do not want to receive future issues of this newsletter or if you have received this in error, please accept our apologies and simply unsubscribe here
Multiple Sclerosis International Federation
3rd Floor Skyline House, 200 Union Street, SE1 0LX
Tel: +44 (0) 20 7620 1911
Fax: +44 (0) 20 7620 1922
Registered Charity: 1105321
Email: info@msif.org
|
|